WHO Living Guidelines on antivirals for COVID-19 are evidence-based

Owen, Andrew; Diaz, Janet Victoria; Guyatt, Gordon; Lamontagne, François; Stegemann, Miriam; Vandvik, Per Olav; Agoritsas, Thomas

doi:10.1016/S0140-6736(22)02306-6

Scientific article

Comment

English

WHO Living Guidelines on antivirals for COVID-19 are evidence-based

ContributorsOwen, Andrew; Diaz, Janet Victoria; Guyatt, Gordon; Lamontagne, François; Stegemann, Miriam

; Vandvik, Per Olav; Agoritsas, Thomas

Published inLancet, vol. 400, no. 10369, p. 2196-2198

Publication date2022-12-17

First online date2022-11-10

Abstract

Comment on : Wu MY, Carr EJ, Harvey R, Mears HV, Kjaer S, Townsley H, Hobbs A, Ragno M, Herman LS, Adams L, Gamblin S, Howell M, Beale R, Brown M, Williams B, Gandhi S, Swanton C, Wall EC, Bauer DLV. WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed. Lancet. 2022 Dec 17;400(10369):2193-2196. doi: 10.1016/S0140-6736(22)01938-9. Epub 2022 Oct 6. PMID: 36209762; PMCID: PMC9536776.

Keywords

Humans
COVID-19
Antiviral Agents / therapeutic use
SARS-CoV-2
World Health Organization

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (ISO format)

OWEN, Andrew et al. WHO Living Guidelines on antivirals for COVID-19 are evidence-based. In: Lancet, 2022, vol. 400, n° 10369, p. 2196–2198. doi: 10.1016/S0140-6736(22)02306-6

Article (Published version)

Identifiers

PID : unige:185702
DOI : 10.1016/S0140-6736(22)02306-6
PMID : 36372074
PMCID : PMC9648976

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0140673622023066

Journal ISSN0140-6736

23views

111downloads

Creation14/03/2025 17:05:12

First validation17/06/2025 15:40:58

Update17/06/2025 15:40:58

Status update17/06/2025 15:40:58

Last indexation17/06/2025 15:40:59

Archive ouverte UNIGE

WHO Living Guidelines on antivirals for COVID-19 are evidence-based

Technical informations